Companies complying with Investigational New Drug (IND)

The FDA's IND program permits pharmaceutical firms to obtain authorization for administering experimental drugs to humans and transporting them across state lines prior to marketing approval, enabling collection of safety and efficacy data.

21,604

companies

List of companies that comply with Investigational New Drug (IND)

CompanyCountryIndustryEmployeesRevenueTechnologies
Country flag

United States

Biotechnology Research

22k

$4.1B

Investigational New Drug (IND)

Country flag

United States

Hospitals and Health Care

740

Investigational New Drug (IND)

Country flag

United States

Manufacturing

2.9k

Investigational New Drug (IND)

Country flag

United States

IT Services and IT Consulting

315k

$6.3B

Investigational New Drug (IND)

Country flag

Spain

Pharmaceutical Manufacturing

60k

$15B

Investigational New Drug (IND)

Country flag

United Kingdom

Banking

85k

$22B

Investigational New Drug (IND)

Country flag

Canada

Non-profit Organizations

1.3k

$11M

Investigational New Drug (IND)

Country flag

United States

Medical Equipment Manufacturing

77k

$19B

Investigational New Drug (IND)

Country flag

United States

Real Estate

19k

$550M

Investigational New Drug (IND)

Country flag

Netherlands

Government Administration

2.8k

Investigational New Drug (IND)

Showing top companies out of 21,604 that comply with Investigational New Drug (IND). Get the full list on TheirStack.

Frequently asked questions